$337M | ||
$259M | ||
$79M | ||
$60M | ||
$58M | ||
$50M |
Buys | $0 | 0 | 0 |
Sells | $27,637,979 | 4 | 100 |
Ricupati Agostino | SVP & CAO | 0 | $0 | 1 | $172,955 | $-172,955 |
Andrews Brian G | EVP, CFO & Treasurer | 0 | $0 | 1 | $2.63M | $-2.63M |
McBride Daniel G | EVP & Chief Operating Officer | 0 | $0 | 1 | $12.13M | $-12.13M |
White Albert G III | President & CEO | 0 | $0 | 1 | $12.71M | $-12.71M |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Over the last 12 months, insiders at The Cooper Companies, Inc. have bought $0 and sold $27.64M worth of The Cooper Companies, Inc. stock.
On average, over the past 5 years, insiders at The Cooper Companies, Inc. have bought $527,254 and sold $35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 889 shares for transaction amount of $249,024 was made by Sheffield Holly R (EVP, CSO) on 2020‑07‑08.
2024-09-19 | Sale | White Albert G III | President & CEO | 114,992 0.0574% | $110.53 | $12.71M | -17.34% | |
2024-09-10 | Sale | Ricupati Agostino | SVP & CAO | 1,601 0.0008% | $108.03 | $172,955 | -15.08% | |
2024-09-05 | Sale | Andrews Brian G | EVP, CFO & Treasurer | 24,788 0.0124% | $105.90 | $2.63M | -13.44% | |
2024-09-04 | Sale | McBride Daniel G | EVP & Chief Operating Officer | 114,992 0.0577% | $105.48 | $12.13M | -12.51% | |
2024-03-18 | Sale | Ricupati Agostino | SVP & CAO | 29,528 0.0149% | $100.89 | $2.98M | -6.30% | |
2024-03-08 | Sale | WEISS ROBERT S | director | 88,075 0.0446% | $102.18 | $9M | -6.65% | |
2024-03-07 | Sale | WEISS ROBERT S | director | 153,213 0.0772% | $102.21 | $15.66M | -7.15% | |
2024-03-05 | Sale | PETERSMEYER GARY S | director | 1,000 0.0005% | $103.51 | $103,506 | -6.46% | |
2024-01-04 | Sale | PETERSMEYER GARY S | director | 150 0.0003% | $336.03 | $50,404 | +3.97% | |
2023-12-19 | Sale | WEISS ROBERT S | director | 79,370 0.1607% | $364.81 | $28.96M | +4.11% | |
2023-12-14 | Sale | PETERSMEYER GARY S | director | 300 0.0006% | $368.55 | $110,565 | +3.62% | |
2023-03-31 | Sale | Ricupati Agostino | SVP & CAO | 1,000 0.002% | $370.00 | $370,000 | +0.04% | |
2023-03-15 | Sale | PETERSMEYER GARY S | director | 700 0.0014% | $335.78 | $235,044 | +9.99% | |
2023-03-09 | Sale | Warner Gerard H III | President, CooperVision, Inc. | 1,216 0.0025% | $340.53 | $414,087 | +10.96% | |
2023-03-07 | Sale | WEISS ROBERT S | director | 37,510 0.0762% | $337.72 | $12.67M | +10.45% | |
2023-01-06 | Sale | Lindell Jody S | director | 1,000 0.002% | $344.30 | $344,304 | +2.85% | |
2022-04-11 | Sale | PETERSMEYER GARY S | 300 0.0006% | $410.55 | $123,165 | -19.73% | ||
2022-04-01 | Sale | Lindell Jody S | 700 0.0014% | $421.04 | $294,728 | -23.75% | ||
2022-03-29 | Sale | WEISS ROBERT S | 2,521 0.0051% | $414.62 | $1.05M | -21.76% | ||
2022-03-18 | Sale | Ricupati Agostino | SVP, Fin & Tax; Chief Actg Off | 4,400 0.0089% | $421.50 | $1.85M | -22.47% |
White Albert G III | President & CEO | 165273 0.0828% | $11.54M | 8 | 10 | +29.23% |
McBride Daniel G | EVP & Chief Operating Officer | 44696 0.0224% | $3.12M | 1 | 16 | <0.0001% |
Andrews Brian G | EVP, CFO & Treasurer | 6614 0.0033% | $461,723.34 | 0 | 3 | |
Ricupati Agostino | SVP & CAO | 4818 0.0024% | $336,344.58 | 1 | 9 | +26.76% |
WEISS ROBERT S | director | 282772 0.1417% | $19.74M | 5 | 26 | +27.93% |
MARX MOSES | director | 102932 0.0516% | $7.19M | 1 | 7 | <0.0001% |
KAUFMAN CAROL R | EVP, Sec. & Chief Gov. Officer | 45943 0.023% | $3.21M | 1 | 17 | +10.48% |
PRESS DONALD | director | 42926 0.0215% | $3M | 3 | 32 | <0.0001% |
Matz Gregory W | SVP, CFO & CRO | 15123 0.0076% | $1.06M | 0 | 4 | |
WHITEFORD STEPHEN | VP, Corporate Controller | 15052 0.0075% | $1.05M | 0 | 3 | |
Lindell Jody S | director | 13543 0.0068% | $945,436.83 | 1 | 16 | +4.36% |
BENDER A THOMAS | director | 12471 0.0063% | $870,600.51 | 4 | 64 | +13.3% |
WEBER JOHN ARTHUR | President, CooperVision, Inc. | 11995 0.006% | $837,370.95 | 2 | 16 | +8% |
ROSENBERG STEVEN | director | 11460 0.0057% | $800,022.60 | 0 | 21 | |
ZINBERG STANLEY MD | director | 10528 0.0053% | $734,959.68 | 2 | 29 | +12.26% |
ACOSTA DAVID | Treasurer | 10000 0.005% | $698,100.00 | 0 | 4 | |
PICHOTTA NICHOLAS J | Pres, CEO Cooper Medical, Inc. | 7463 0.0037% | $520,992.03 | 0 | 21 | |
FOLDEN RODNEY | VP & Corporate Controller | 6682 0.0033% | $466,470.42 | 0 | 7 | |
KALKSTEIN MICHAEL | director | 5838 0.0029% | $407,550.78 | 0 | 23 | |
PETERSMEYER GARY S | director | 5668 0.0028% | $395,683.08 | 0 | 22 | |
NEIL STEVEN M | EVP & CFO | 4300 0.0022% | $300,183.00 | 3 | 0 | +3.22% |
BATTIN B NORRIS | VP, Investor Relations | 4000 0.002% | $279,240.00 | 2 | 3 | +11.54% |
FRYLING GREGORY A | Pres & COO - CVI | 3790 0.0019% | $264,579.90 | 0 | 11 | |
RUBENSTEIN ALLAN E | director | 3091 0.0015% | $215,782.71 | 1 | 55 | +15.96% |
CUMMINS EDGAR J | director | 1764 0.0009% | $123,144.84 | 0 | 2 | |
REMMELL PAUL L | Pres & CEO - CooperSurgical | 1352 0.0007% | $94,383.12 | 0 | 18 | |
Sheffield Holly R | EVP, CSO | 1414 0.0007% | $98,711.34 | 2 | 0 | +25.76% |
Auerbach Robert D | Special Advisor to the CEO | 1403 0.0007% | $97,920.88 | 0 | 3 | |
Golden Randal | VP, General Counsel & Sec. | 1148 0.0006% | $80,141.88 | 0 | 5 | |
Warner Gerard H III | President, CooperVision, Inc. | 1290 0.0006% | $90,054.90 | 0 | 1 | |
KOZY WILLIAM A | director | 770 0.0004% | $53,753.70 | 1 | 0 | +3.83% |
FRUTH JOHN D | director | 0 0% | $0 | 0 | 28 | |
CALCAGNO JOHN J | CFO - CooperVision | 0 0% | $0 | 0 | 7 | |
WELCH JAMES M | Vice President Intl Ops - CVI | 0 0% | $0 | 0 | 1 | |
Midlock Eugene J | Sr. VP and CFO | 0 0% | $0 | 1 | 3 | <0.0001% |
McLean Jeffrey Alan | Exec VP, Comm. Strategies-CVI | 0 0% | $0 | 0 | 2 | |
Sedgwick Andrew | President, EMEA | 0 0% | $0 | 0 | 1 | |
Murphy Dennis | President Americas, CVI | 0 0% | $0 | 0 | 2 |
Increased Positions | 303 | +37.92% | 21M | +10.72% |
Decreased Positions | 354 | -44.31% | 16M | -8.35% |
New Positions | 70 | New | 3M | New |
Sold Out Positions | 102 | Sold Out | 5M | Sold Out |
Total Postitions | 748 | -6.38% | 201M | +2.38% |
Vanguard Group Inc | $1.96M | 11.93% | 23.85M | -40,579 | -0.17% | 2024-12-31 |
Blackrock, Inc. | $1.26M | 7.65% | 15.29M | -924,108 | -5.7% | 2025-03-31 |
State Street Corp | $714,664.00 | 4.34% | 8.68M | +92,959 | +1.08% | 2024-12-31 |
Kayne Anderson Rudnick Investment Management Llc | $665,221.00 | 4.04% | 8.08M | +2,237 | +0.03% | 2024-12-31 |
T. Rowe Price Investment Management, Inc. | $631,979.00 | 3.84% | 7.68M | +155,233 | +2.06% | 2024-12-31 |
Jpmorgan Chase & Co | $411,872.00 | 2.5% | 5M | +74,501 | +1.51% | 2024-12-31 |
Geode Capital Management, Llc | $403,802.00 | 2.45% | 4.91M | +109,907 | +2.29% | 2024-12-31 |
Invesco Ltd. | $398,898.00 | 2.42% | 4.85M | -147,164 | -2.95% | 2024-12-31 |
Alliancebernstein L.P. | $372,818.00 | 2.27% | 4.53M | -521,421 | -10.32% | 2024-12-31 |
Victory Capital Management Inc | $371,935.00 | 2.26% | 4.52M | -5,754 | -0.13% | 2025-03-31 |